期刊文献+

MUC1/Y基因体外冲击树突状细胞诱导抗瘤免疫反应 被引量:1

The clinical senses of MUC1/Y gene expressing in gastrointestinal cancer and MUC1/Y modified DC inducing anti-tumor response
下载PDF
导出
摘要 目的 :制备含MUC1 YcDNA质粒转染的树突状细胞 (DC) ,体外诱导杀伤细胞 ,研究其治疗消化道肿瘤的效果。方法 :构建MUC1 YcDNA真核表达载体pIRES2 EGFP MUC1 Y、pcDNA3 1 MUC1 Y。以pcDNA3 1 MUC Y电转染 8例HLA A2 ( + )消化道肿瘤患者单个核细胞衍生的DC后 ,与自体T细胞混合培养 ,诱导CTL(T pcDAN3 1 MUC1 Y)。以SW6 2 0细胞 [HLA A2 ( + ) 、MUC1 Y( + ) ]为特异性靶细胞 ,Raji细胞 [HLA A2 ( - ) 、MUC1 Y( - ) ]和Lovo细胞 [HLA A2 ( - ) 、MUC1 Y( + ) ]为非特异性靶细胞 ,通过乳酸脱氢酶 (LDH)释放实验测定杀伤活性 ,ELISA法检测基因修饰后DC刺激自体T细胞产生IFN γ的能力 ,并以AN NEXINV FITC试剂盒检测特异性CTL诱导靶细胞凋亡情况。结果 :pIRES2 EGFP MUC1 Y转染效率为 8%左右。T pcDAN3 1 MUC1 Y诱导的杀伤作用显著高于T pcDNA3 1[pcDNA3 1(+)修饰DC诱导的CTL]和T IL 2 (IL 2刺激外周血单个核细胞产生的CTL) ,P <0 0 5。而且T pcDNA3 1 MUC1 Y对靶细胞的杀伤和诱导凋亡的能力显著高于对照组。基因修饰后的DC能刺激自体T细胞分泌高水平IFN γ ,与未转染的DC相比具有显著差异 (P <0 0 5 )。结论 :成功构建MUC1 Y全长cDNA真核表达载体。pIRES2 EGFP MUC1 Y可用于真核细胞转染 ,通过观察转? Objective:For developing the study of MUC1/Y vaccine,constructed th eukaryotic expression vectors expressing MUC1/Y.Used it to modify the DC inducint CTL in order to treat the gastrointestinal cancers.Methods:Obtained the MCU1/Y cDNA full length cloned it into pIRES2 EGFP that expressing green fluorescence protein and pcDAN3 1+ respectively.Selected 8 cases of gastrointestinal cancer whose HLA phenotype was A2,inducing DC using rhIL 4 combined with GM CSF in vitro.Transfected DC with pcDAN3.1 MUC1/Y then co cultured DC with T cell to induce CTL (named as T pcDAN3 1 MUC1/Y).At the same time,used pIRES2 EGFP MUC1/Y to detect transfection efficiency.SW620 (HLA A2+,MUC1/Y+),the gastric cancer cell line was used as specific target cell;Lovo(HLA A2 ,MUC1/Y+)and Raji(HLA A2 ,MUC1/Y )were used as unspecific target cells.The cytolytic of specific CTL was measured by LDH releasing assay.The apoptosis of target cells were detected by ANNEXIN V FITC kit.The ability of IFN γ releasing of T cells was measured by ELISA.Results:The transfection efficiency of plasmid was about 8%.There was significant difference between the cytolytic activity of T pcDNA3 1 MUC1/Y to SW620,Lovo and Raji.The cytolytic activity was about (42 8±6 15),(27 26±1 96)% and (22 73±2 15)% respectively.Compared with T IL 2)CTL induced by PBMC stimulated of IL 2(100 U/ml)) and T pcDNA3 1(CTL induced by DC transfected by pcDNA3 1+),the cytolytic activity of T pcDNA3 1 MUC1/Y against SW620 cell line showed a significant increase.The results of ANNEXIN V-FITC experimences showed that T pcDNA3 1 MUC1/Y could induce apoptosis of specific target cell.Conclusion:The expressing of MUC1/Y mRNA has important sense in gastrointestinal cancer.Constructed eukaryotic vector pIRES2 EGFP MUC1/Y that contains full length MUC1/Y cDNA could be used to study the transfection efficiency and select the positive clone;pcDAN3 1 MYC1/Y could induce powerful CTL immunoresponse.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2004年第7期461-466,共6页 Chinese Journal of Immunology
基金 天津市教委科技基金资助项目 (9910 0 1)
关键词 消化道肿瘤 MUC1/Y 基因疫苗 Gastrointestinal cancer MUC1/Y Gene vaccine
  • 相关文献

参考文献10

  • 1Irimura T,Denda K,Iida Si et al. Diverse glycosylation of MUC1 and MUC2:potential significance in tumor immunity[J].J Biochem (Tokyo),1999;126(6):975-985.
  • 2Zrihan-Licht S,Vos H L,Baruch A et al.Characterization and molecular cloning of a novel MUC1 protein,devoid of tandem repeats,expressed in human breast cancer tissue[J].Eur J Biochem,1994;224(2):787-795.
  • 3Baruch A,Hartmann M,Zrihan-Licht S et al.Preferential expression of novel MUC1 tumor antigen isoforms in human epithelial tumors and their tumor-potentiating function[J].Int J Cancer,1997;71(5):741-749.
  • 4Pecher G,Spahn G,Schirrmann T et al.Mucin gene(MUC1)transfer into human dendritic cells by cationic liposomes and recombinant adenovirus[J].Anticancer Res,2001;21(4A):2591-2596.
  • 5Scambia G,Lavitrano M,Frati L et al.Transfected human dendritic cells to induce antitumor immunity[J].Gene Ther,2000;7(17):1458-1466.
  • 6Brossart M D.Dendritic cells in vaccination therapies of malignant diseases[J].Transfus Apheresis Sci,2002;27(2):183-186.
  • 7Hartman M,Baruch A,Ron I et al.MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancer[J].Int J Cancer,1999;82(2):256-267.
  • 8李琤,任秀宝.MUC1粘蛋白在肿瘤免疫治疗中的研究[J].国外医学(免疫学分册),2002,25(4):175-177. 被引量:3
  • 9张立新,李春海.MUC1粘蛋白的免疫生物学作用及其在肿瘤生物学治疗中的应用[J].中国肿瘤生物治疗杂志,2000,7(3):165-170. 被引量:33
  • 10张立新,李春海,孙丽亚.肿瘤MUC1/Y的克隆及其胞外段在大肠杆菌中的可溶性表达、纯化和鉴定[J].中国生物化学与分子生物学报,2001,17(5):579-584. 被引量:6

二级参考文献22

  • 1Seregni E, Botti C, Massaron S, et al. [J]. Tumori, 1997, 83(3); 625-632.
  • 2Berois N, Varangot M, Aizen B, et al. [J]. Eur J Cancer, 2000, 36(6): 717-723.
  • 3Von Mensdorff-Pouilly S,Snijdewint FG, Venstraeten AA, et al.[J] Int J Biol Markers, 2000,15(4): 343-356.
  • 4Morse MA. [J]. Curr Opin Mol Ther, 2001, 3(1): 102-105.
  • 5Finn OJ, Gendler SJ. [J]. Nat Biotechnol, 1998, 16(3): 236-237.
  • 6Xing PX, Apoetolopoulos V, Pietersz G, et al. [J]. Front Biosci, 2001, 6: D1283-1295.
  • 7Von Mensdorff-Pouilly S, Snijdewint FG, Verstraeten AA, et al.[J]. Int J Biol Markers, 2000,15(4): 343-356.
  • 8Avichezer D, Taylor-Papadimitriou J, Amon R. [J]. Cancer Biochem Biophys, 1998, 16(1-2): 113-128.
  • 9Goydos JS, Elder E, Whiteside TL, et al. [J]. J Surg Res, 1996, 63(1); 298-304.
  • 10Barratt-Boyes SM. [J]. Cancer Immunol Immunother, 1996, 43(3): 142-151.

共引文献36

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部